Alx Oncology Holdings (ALXO) Total Non-Current Liabilities (2019 - 2026)

Alx Oncology Holdings has disclosed Total Non-Current Liabilities across 8 years of filings, most recently posting $23.5 million for Q1 2026.

• Total Non-Current Liabilities for Q1 2026 came in at $23.5 million, down 12.98% year-over-year; the trailing twelve-month figure through Mar 2026 was $23.5 million (down 12.98% YoY), and the FY2025 annual result was $29.1 million, up 3.99% from the prior year.
• Total Non-Current Liabilities came in at $23.5 million for Q1 2026 at Alx Oncology Holdings, down from $29.1 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $48.2 million in Q2 2024 to a low of $15.3 million in Q1 2022.
• The 5-year median for Total Non-Current Liabilities is $29.1 million (2025), against an average of $32.4 million.
• Across the five-year window, Total Non-Current Liabilities surged 146.58% in 2022 and plunged 46.4% in 2025, its largest moves.
• Alx Oncology Holdings' Total Non-Current Liabilities stood at $37.7 million in 2022, then rose by 21.02% to $45.6 million in 2023, then plunged by 38.72% to $28.0 million in 2024, then increased by 3.99% to $29.1 million in 2025, then dropped by 19.3% to $23.5 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $23.5 million (Q1 2026), $29.1 million (Q4 2025), and $33.5 million (Q3 2025), per Business Quant data.